Browsing by 저자 : Jee Hyun Kim
전체 결과 18건 중 1-18 번을 표시중입니다.
-
1
Article
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer
정경해
;
Cassandra Slader
;
Chien-Ting Liu
;
et al
2021
-
2
Article
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer
정경해
;
Cassandra Slader
;
Chien-Ting Liu
;
et al
2021
-
3
Article
A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)
Dae-Won Lee
;
Bhumsuk Keam
;
Keun Seok Lee
;
et al
2023
-
4
Article
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
Se Hyun Kim
;
Seock-Ah Im
;
Koung Jin Suh
;
et al
2023
-
5
Article
COMPrehensive geriatric AsseSSment and multidisciplinary team intervention for hospitalised older adults (COMPASS): a protocol of pragmatic trials within a cohort
Jung-Yeon Choi
;
Ji Yeon Lee
;
Jaeyong Shin
;
et al
2022
-
6
Article
Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer
Soohyeon Lee
;
Kyunghee Park
;
Gun Min Kim
;
et al
2022
-
7
Article
Factors associated with stigma and depressive symptoms in family members of patients with epilepsy
염미선
;
이상암
;
Dong Jin Shin
;
et al
2020
-
8
Article
FOXO1 Is a Key Mediator of Glucocorticoid-Induced Expression of Tristetraprolin in MDA-MB-231 Breast Cancer Cells
Do Yong Jeon
;
So Yeon Jeong
;
Ju Won Lee
;
et al
2022
-
9
Article
Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer
Kyoungmin Lee
;
Jongwon Lee
;
Jungmin Choi
;
et al
2023
-
10
Article
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
Changhwan Sung
;
Jinhyeon An
;
Soohyeon Lee
;
et al
2023
-
11
Article
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Josep M Llovet
;
Masatoshi Kudo
;
Philippe Merle
;
et al
2023
-
12
Article
Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)
고수진
;
정경해
;
Gun Min Kim
;
et al
2020
-
13
Article
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B)
Sung Hoon Sim
;
Jeong Eun Kim
;
Min Hwan Kim
;
et al
2022
-
14
Article
Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy
고수진
;
홍용상
;
Eun Kyeong Chun
;
et al
2020
-
15
Article
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
류백렬
;
Ann-Li Cheng
;
Chia Jui Yen
;
et al
2021
-
16
Article
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
Shinkyo Yoon
;
Miso Kim
;
Yong Sang Hong
;
et al
2022
-
17
Article
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer
Hee Kyung Ahn
;
Sung Hoon Sim
;
Koung Jin Suh
;
et al
2022
-
18
Article
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study
Jwa Hoon Kim
;
Seyoung Seo
;
Jee Hyun Kim
;
et al
2022